Ethinylestradiol/gestodene
 Ethinylestradiol | |
 Gestodene | |
| Combination of | |
|---|---|
| Ethinylestradiol | Estrogen |
| Gestodene | Progestogen; Progestin |
| Clinical data | |
| Trade names | Femodene, Gynera, Harmonet, Lindynette, Logest, Meliane, Minesse, Minulet, Mirelle, others |
| Other names | EE/GSD |
| Routes of administration | By mouth |
| Drug class | Estrogen; Progestin; Progestogen |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
Ethinylestradiol/gestodene (EE/GSD), sold under the brand names Femodene and Minulet among others, is a combination of ethinylestradiol (EE), an estrogen, and gestodene (GSD), a progestin, which is used as a birth control pill to prevent pregnancy in women.[1][2] It is taken by mouth and contains 20 or 30 μg EE and 0.075 mg GSD per tablet.[1][2] EE/GSD is marketed widely throughout the world.[3]
See also
References
- 1 2 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 440–. ISBN 978-92-832-1291-1.
- 1 2 Bartke A, Constanti A (9 July 2003). Basic Endocrinology. Taylor & Francis. pp. 128–. ISBN 978-1-135-29850-0.
- ↑ "Gestodene". drugs.com.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.